0001104659-19-049587.txt : 20190910 0001104659-19-049587.hdr.sgml : 20190910 20190910180029 ACCESSION NUMBER: 0001104659-19-049587 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190906 FILED AS OF DATE: 20190910 DATE AS OF CHANGE: 20190910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENBERG MORRIS CENTRAL INDEX KEY: 0001202786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 191086332 MAIL ADDRESS: STREET 1: C/O SAETTLE GENETICS INC STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 a4.xml 4 X0306 4 2019-09-06 0 0000722830 IMMUNOMEDICS INC IMMU 0001202786 ROSENBERG MORRIS C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 0 1 0 0 Chief Technology Officer Stock Option (right to buy) 13.19 2019-09-06 4 A 0 67480 0 A 2020-09-06 2026-09-06 Common Stock, par value $0.01 per share 67480 67480 D The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and in 6.25% in equal quarterly installments over a three-year period thereafter. /s/ Morris Rosenberg 2019-09-09